NDC 51662-1548
VERAPAMIL HCI
Verapamil Hci
VERAPAMIL HCI is a Intravenous Injection, Solution in the Human Prescription Drug category. It is labeled and distributed by Hf Acquisition Co Llc, Dba Healthfirst. The primary component is Verapamil Hydrochloride.
| Product ID | 51662-1548_df7a677c-e654-5f4b-e053-2995a90a06b3 |
| NDC | 51662-1548 |
| Product Type | Human Prescription Drug |
| Proprietary Name | VERAPAMIL HCI |
| Generic Name | Verapamil Hci |
| Dosage Form | Injection, Solution |
| Route of Administration | INTRAVENOUS |
| Marketing Start Date | 2022-05-20 |
| Marketing Category | ANDA / |
| Application Number | ANDA212965 |
| Labeler Name | HF Acquisition Co LLC, DBA HealthFirst |
| Substance Name | VERAPAMIL HYDROCHLORIDE |
| Active Ingredient Strength | 3 mg/mL |
| Pharm Classes | Calcium Channel Antagonists [MoA], Calcium Channel Blocker [EPC], Cytochrome P450 3A Inhibitors [MoA], Cytochrome P450 3A4 Inhibitors [MoA], P-Glycoprotein Inhibitors [MoA] |
| NDC Exclude Flag | N |
| Listing Certified Through | 2023-12-31 |